Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of GUCY1B3 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | ELISA,WB-Ce |
More info about GUCY1B3 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB4059 |
| Product name: | GUCY1B3 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of GUCY1B3. |
| Gene id: | 2983 |
| Gene name: | GUCY1B3 |
| Gene alias: | GC-S-beta-1|GC-SB3|GUC1B3|GUCB3|GUCSB3|GUCY1B1 |
| Gene description: | guanylate cyclase 1, soluble, beta 3 |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human GUCY1B3. |
| Protein accession: | NP_000848 |
| Form: | Liquid |
| Recommend dilutions: | ELISA (1:1000) Western Blot (1:100-500) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis of GUCY1B3 polyclonal antibody (Cat # PAB4059) in Y-79 cell lysate. GUCY1B3 (arrow) was detected using the purified polyclonal antibody. |
| Applications: | ELISA,WB-Ce |
| Shipping condition: | Dry Ice |
| Publications: | Guanylyl cyclases and signaling by cyclic GMP.Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA. Pharmacol Rev. 2000 Sep;52(3):375-414. |